[Federal Register Volume 87, Number 189 (Friday, September 30, 2022)]
[Notices]
[Pages 59430-59431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21215]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-22-22FI]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``National HIV Behavioral Surveillance 
System: Brief HIV Bio-behavioral Assessment (NHBS-BHBA)'' to the Office 
of Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on May 13, 2022 to obtain comments from the 
public and affected agencies. CDC received one comment related to the 
previous notice. This notice serves to allow an additional 30 days for 
public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    National HIV Behavioral Surveillance: Brief HIV Bio-behavioral 
Assessment (NHBS-BHBA)--New--National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The purpose of National HIV Behavioral Surveillance: Brief HIV Bio-
behavioral Assessment (NHBS-BHBA) is to monitor behaviors of 
populations at high risk for Human Immunodeficiency Virus (HIV) 
infection using mixed-methods in selected geographic areas in the 
United States which lack biobehavioral data related to HIV transmission 
and prevention.
    Preventing HIV, especially among populations at high risk, is an 
effective strategy for reducing individual, local, and national 
healthcare costs. The utility of this information is to provide CDC and 
health department staff with data for evaluating progress towards state 
public health goals, such as reducing new HIV infections, increasing 
the use of condoms, and focusing on populations at high risk by 
describing and monitoring the HIV risk behaviors, HIV seroprevalence 
and incidence, and HIV prevention experiences of persons at highest 
risk for HIV infection.
    The Centers for Disease Control and Prevention (CDC) requests a 
three-year approval for a new information collection. Data will be 
systematically collected using mixed methods of quantitative and 
qualitative interviews. Brief screening interviews will be used to 
determine eligibility for participation in the quantitative and 
qualitative interviews.
    Project areas will conduct brief standardized quantitative 
interviews and anonymous HIV blood-based rapid testing and supplemental 
testing to those who participate in quantitative data collection to 
assess HIV seroprevalence. The data from the quantitative interviews 
will provide estimates of: (1) behavior related to the risk of HIV and 
other sexually transmitted diseases; (2) prior testing for HIV; and (3) 
use of HIV prevention services. HIV screening results will be made 
available to participants, and those with preliminary positive test 
results will be linked to HIV care. Qualitative data collection 
includes key informant interviews with community

[[Page 59431]]

members and professionals familiar with the population and focus groups 
to interpret standardized quantitative findings and inform grantee-
developed recommendations for state/local public health partners. The 
data from qualitative interviews will be used to interpret standardized 
quantitative findings and inform recipient-developed recommendations 
for state and local public health authorities. No other federal agency 
collects this type of information in the populations at high risk in 
these selected geographic areas using mixed methods of quantitative and 
qualitative interviews.
    CDC estimates that during quantitative interviewing, 1338 
individuals will complete the quantitative base eligibility screener, 
1204 will complete the quantitative population eligibility screener, 
and 338 will be either not interested or ineligible, yielding a total 
of 1000 eligible respondents over a 12-month period. For qualitative 
data collection approximately 96 individuals will complete the 
eligibility screener, 16 of the respondents will be either not 
interested in completing a qualitative interview, or will be 
ineligible, yielding a total of 80 eligible respondents over a 12-month 
period.
    The total estimated annualized burden requested is 497 hours. 
Participation of is voluntary, and there are no costs to respondents 
other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Persons Screened......................  Quantitative Base                   1338               1            1/60
                                         Eligibility Screener.
Persons Screened......................  Quantitative Population             1204               1            5/60
                                         Eligibility Screener.
Eligible Participants.................  Quantitative Core Survey            1000               1           10/60
Eligible Participants.................  Quantitative Population-            1000               1            5/60
                                         specific Questions.
Persons Screened......................  Qualitative Eligibility               96               1            1/60
                                         Screener.
Eligible Participant..................  Qualitative interviews..              80               1           90/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-21215 Filed 9-29-22; 8:45 am]
BILLING CODE 4163-18-P